The FDA's breakthrough therapy designation facilitates accelerated development and regulatory review for therapies showing ...

Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based ...

Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an ...

A recent study by Vanderbilt Health researchers has revealed a greater, detrimental role for B lymphocytes (B cells) in the ...

Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.

Amlitelimab, an OX40 ligand–targeting therapy that modulates T-cell-mediated inflammation without causing cell depletion, ...

A new study led by researchers at the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer ...

A Virginia real estate developer wants a U.S. District Court judge to dismiss a lawsuit surrounding a north Boulder cell tower. New Cingular Wireless, a legal entity of AT&T, is suing MJF 2801 Jay ...

Each immune cell group has distinct metabolic requirements, activation pathways, and cytokine reliance. Standard, one-size-fits-all media cannot address these features. When studying diverse cell ...

“Stem cell therapy and research are still effectively banned in South Africa,” Dr Mia said. “That hasn’t changed in law. What ...